Substance misuse continues to pose a significant challenge in the United States. Prevention, defined as any action aimed at averting substance misuse and lessening its adverse health and societal impacts,…
MindMed (NASDAQ: MNMD), a clinical-stage biopharmaceutical company focused on developing innovative treatments for brain health disorders, unveiled data from its Phase 2b study of MM120 (lysergide d-tartrate) for treating Generalized…
Today, Mars, Incorporated revealed it’s in exclusive talks with Cerba HealthCare, aiming to acquire Cerba HealthCare’s ownership stake in Cerba Vet and ANTAGENE Based in Massy, France, Cerba Vet operates…
Cynergy Wellness to provide clinician oversight of BetterWay™ customer-initiated blood testing orders Babson Diagnostics, a pioneering healthcare technology company with a focus on science, has announced a collaboration with Cynergy…
TriSalus Life Sciences Inc. (Nasdaq: TLSI) has finalized a debt financing agreement of up to $50 million with OrbiMed, a leading healthcare investment firm. This capital infusion aims to offer…
AndHealth has teamed up with the Ohio Association of Community Health Centers (OACHC) to introduce a statewide Whole-Person Community Care Model for Ohio’s Community Health Centers (CHCs) and their patients.…
Heidelberg Engineering invites ARVO delegates to explore its cutting-edge imaging technology across various applications, spanning from fundamental vision research to clinical trials and guided therapy. These advancements, rooted in diagnostic…
Locate Bio, an innovative orthobiologics firm, has concluded an oversubscribed £9.2 million funding round with support from new and existing investors, including Mercia Ventures and BGF. The funding will facilitate…
The top-line findings from the DESTINY-Breast06 phase 3 trial reveal a significant advancement with ENHERTU® (trastuzumab deruxtecan). Compared to standard chemotherapy, ENHERTU demonstrated both statistically and clinically significant enhancements in…
Incyte (Nasdaq:INCY) has entered a definitive agreement to acquire Escient Pharmaceuticals, a clinical-stage company focused on developing novel small molecule therapeutics for systemic immune and neuro-immune disorders. This acquisition includes…
LabVantage Solutions, Inc., a leading provider of laboratory IT solutions, has announced the completion of over 100 software deployments in fiscal year 2024 across various industries, including pharmaceuticals, biotechnology, healthcare,…
On April 16, 2024, Saga University Hospital and BostonGene (based in Waltham, Massachusetts, U.S.) forged a collaboration aimed at advancing biomarker research to predict the efficacy of immune checkpoint inhibitors…